News

Careful Use of Gout Drugs Can End Acute Attacks


 

General internists often continue to treat gout the way they were taught to as medical students, and the result of that approach has been that patients continue to have gout attacks and joint damage. Physicians can do much better than that by using available medications to lower the patient’s serum urate level below 6 mg/dL, according to Dr. Brian Mandell, Professor and Chairman of Medicine at the Cleveland Clinic. This interview was conducted at the 5th Annual Perspectives in Rheumatic Diseases Seminar.

Recommended Reading

Ilaris: FDA Asks if Gout Symptom Relief Is Worth Infection Risks
MDedge Internal Medicine
FDA Panel Votes Against Biologic for Gouty Arthritis Flares
MDedge Internal Medicine
Gout by the Numbers
MDedge Internal Medicine
Gout Prevalence on the Upswing, MDs on the Downswing
MDedge Internal Medicine
Obesity Epidemic Is Skewing Face of Gout
MDedge Internal Medicine
Physicians Often Missing Boat on Gout Therapy
MDedge Internal Medicine
Colchicine Halved MI Risk in Gout
MDedge Internal Medicine
Gout Prevalence Has Spiked
MDedge Internal Medicine
Biologic Gout Drug Fails the FDA Panel Sniff Test
MDedge Internal Medicine
New Gout Guidelines Inspired by Recent Data
MDedge Internal Medicine